Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia.
暂无分享,去创建一个
M. Verneris | D. Bhojwani | M. Burke | Kristen Campbell | K. Maloney | N. Gossai | A. Keating | C. Phillips | Andrew Doan | A. Doan